Salinomycin enhances doxorubicin sensitivity through reversing the epi
- This topic has 0 replies, 1 voice, and was last updated 6 years, 11 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
Salinomycin enhances doxorubicin sensitivity through reversing the epithelial-mesenchymal transition of cholangiocarcinoma cells by regulating ARK5.
https://www.ncbi.nlm.nih.gov/pubmed/28832761
Viewing 1 post (of 1 total)
- The forum ‘New Developments’ is closed to new topics and replies.